Evaluation and treatment approaches for neurological post-acute sequelae of COVID-19: A consensus statement and scoping review from the global COVID-19 neuro research coalition

J Neurol Sci. 2023 Nov 15:454:120827. doi: 10.1016/j.jns.2023.120827. Epub 2023 Oct 13.

Abstract

Post-acute neurological sequelae of COVID-19 affect millions of people worldwide, yet little data is available to guide treatment strategies for the most common symptoms. We conducted a scoping review of PubMed/Medline from 1/1/2020-4/1/2023 to identify studies addressing diagnosis and treatment of the most common post-acute neurological sequelae of COVID-19 including: cognitive impairment, sleep disorders, headache, dizziness/lightheadedness, fatigue, weakness, numbness/pain, anxiety, depression and post-traumatic stress disorder. Utilizing the available literature and international disease-specific society guidelines, we constructed symptom-based differential diagnoses, evaluation and management paradigms. This pragmatic, evidence-based consensus document may serve as a guide for a holistic approach to post-COVID neurological care and will complement future clinical trials by outlining best practices in the evaluation and treatment of post-acute neurological signs/symptoms.

Keywords: COVID-19; Diagnosis; Evaluation; Management; Neurologic; SARS-COV-2; Therapeutics; Therapy; Treatment.

Publication types

  • Review
  • Research Support, N.I.H., Extramural

MeSH terms

  • Anxiety / etiology
  • Anxiety / therapy
  • COVID-19* / complications
  • Cognitive Dysfunction*
  • Consensus
  • Diagnosis, Differential
  • Disease Progression
  • Dizziness / diagnosis
  • Dizziness / etiology
  • Dizziness / therapy
  • Humans